MSD
A senior scientific leader in drug metabolism who will head the Biotransformation (MetID) group within the Drug Metabolism & Pharmacokinetics (DMPK) department, guiding metabolite identification strategies and supervising a team of scientists to support drug discovery and development projects.
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MSD.
62% above the average for this role
MSD ends takeover talks with Revolution Medicines
1 month ago
Director, Pharmacokinetics
Merck & Co., Inc.
Director, Pharmacokinetics
Merck & Co., Inc.
Senior Scientist, Pharmacokinetics
Merck & Co., Inc.
Senior Scientist, Biotransformation
Bristol Myers Squibb
Senior Principal Scientist - Drug Metabolism and Pharmacokinetics (m/f/d)
City of Duncan, Oklahoma
Scientist II/Senior Scientist I, DMPK
Zealand Pharma